Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

Delayed Quote. Delayed  - 08/30 05:30:39 pm
242.9 CHF   +0.37%
08:49aDJBusiness Watch -- WSJ
08/29 ROCHE : démarre ses tests contre le virus Zika
08/29 CHUGAI PHARMACE : receives Orphan Drug Designation for Emicizumab; P..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
08/24/2016 08/25/2016 08/26/2016 08/29/2016 08/30/2016 Date
243.5(c) 240.3(c) 240.9(c) 242(c) 242.9 Last
1 057 118 1 407 732 877 127 711 091 1 162 837 Volume
-0.49% -1.31% +0.25% +0.46% +0.37% Change
More quotes
Financials ( CHF)
Sales 2016 51 267 M
EBIT 2016 18 023 M
Net income 2016 11 303 M
Debt 2016 11 050 M
Yield 2016 3,54%
Sales 2017 53 910 M
EBIT 2017 19 288 M
Net income 2017 12 712 M
Debt 2017 5 315 M
Yield 2017 3,75%
P/E ratio 2016 18,13
P/E ratio 2017 16,25
EV / Sales2016 4,28x
EV / Sales2017 3,97x
Capitalization 208 615 M
More Financials
Company
Roche Holding AG operates as a research healthcare company.It operates through the diagnostics and pharmaceuticals segments.The pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience.The diagnostic segment... 
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
08:49aDJBusiness Watch -- WSJ
08/29 ROCHE : démarre ses tests contre le virus Zika
08/29 CHUGAI PHARMACEUTICAL : receives Orphan Drug Designation for Emicizumab; Prevent..
08/29 CHUGAI PHARMACEUTICAL : Anti-Cancer Agent 'Xeloda,'Obtained Approval for Additio..
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test -- Update
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test
08/29 CHUGAI PHARMACEUTICAL : Kowa Company Enters into Licensing Agreement with Chugai..
08/26 ROCHE : Taraba, Firm Plan N1.3 Billion Scheme to Tackle Hepatitis
08/26 CHUGAI PHARMACEUTICAL : Application for Approval of Additional Dosage for 'Actem..
08/26 ROCHE : Diagnostics Operations Assigned Patent
More news
Sector news : Pharmaceuticals - NEC
08/29 Mylan to launch generic EpiPen at half the price of original
08/29DJMondelez Walks Away After Hershey Spurns Raised Bid
08/29DJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/29 WALL STREET BREAKFAST : Week Of Economic Data Up Next
08/29 Roche gets emergency clearance for Zika test
08/26 Denali Lets Rip With Biggest Funding Round
08/26 A Merck Versus Bristol Showdown
08/26 New use of Roche's Xeloda OK'd in Japan
Advertisement
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Technical analysis trends ROCHE HOLDING LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 300  CHF
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Daniel O'Day COO-Roche Pharmaceuticals Division
Roland Diggelmann COO-Roche Diagnostics Division
Alan Hippe Chief Financial & Information Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-12.84%212 954
JOHNSON & JOHNSON16.74%328 086
PFIZER INC.8.77%212 965
NOVARTIS AG-10.83%208 887
MERCK & CO., INC.19.29%174 236
ASTRAZENECA PLC7.33%173 471
More Results